Efficacy and safety of ozanimod in older patients with ulcerative colitis (UC): post hoc analysis of the True North study

被引：0
|
作者：
Chandwe, Kanta [1 ]
Bwakura-Dangarembizi, Mutsa [2 ]
Amadi, Beatrice [1 ]
Tawodzera, Gertrude [2 ]
Murch, Simon [3 ]
Hill, Susan [4 ]
Playford, Ray [5 ,6 ]
VanBuskirk, Kelley [1 ]
Prendergast, Andrew [2 ,7 ]
Kelly, Paul [7 ]
机构：
[1] Univ Zambia, Trop Gastroenterol & Nutr Grp, Lusaka, Zambia
[2] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe
[3] Med Sch, Warw kUnivers, Coventry, England
[4] Great Ormond St Hosp Sick Children, London, England
[5] Univ West London, London, England
[6] Univ Coll Cork, Cork, Ireland
[7] Barts & London Queen Mary Univ London, London, England
来源：
GUT | 2023年 / 72卷 / SUPPL_2期
关键词：
D O I：
10.1136/gutjnl-2023-BSG.172
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P100
引用
收藏
页码：A107 / A107
页数：1
相关论文
共 50 条
  • [41] Long-term Safety of Ozanimod in Patients with Moderately to Severely Active Ulcerative Colitis (UC) and Relapsing Multiple Sclerosis (RMS) Studies
    Rubin, David T.
    Wolf, Douglas C.
    Alekseeva, Olga
    Charles, Lorna
    Afsari, Sonia
    Petersen, Ann Katrin
    Sheffield, James
    Li, Hongjuan
    Silva, Diego
    Lublin, Fred D.
    Cree, Bruce
    Cohen, Jeffrey
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S396 - S396
  • [42] LONG-TERM SAFETY OF 3 YEARS OF OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: AN INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION
    Abreu, Maria T.
    Danese, Silvio
    Wolf, Douglas C.
    Canavan, James B.
    Jain, Anjali
    Wu, Hsiuanlin
    Petersen, AnnKatrin
    Charles, Lorna
    Afzali, Anita
    Panaccione, Remo
    GASTROENTEROLOGY, 2023, 164 (06) : S208 - S208
  • [43] EXTENDED THERAPY WITH OZANIMOD FOR DELAYED RESPONDERS TO OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY
    Panaccione, Remo
    Afzali, Anita
    Hudesman, David
    Lawlor, Garrett
    Osterman, Mark T.
    Eren, Devrim
    Memaj, Arteid
    Regueiro, Miguel D.
    Ghosh, Subrata
    GASTROENTEROLOGY, 2022, 162 (07) : S965 - S965
  • [44] REAL-WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD IN ULCERATIVE COLITIS: A MULTICENTER STUDY
    Lieto, Stephen
    Scalzo, Nicholas
    Huang, Katherine
    Khan, Abdul
    Xu, Anthony
    Pekow, Joel
    Rajauria, Palak
    Ayoub, Malek
    Johnson, Amanda M.
    Yarur, Andres
    Patel, Anish
    Bishu, Shrinivas
    Shukla, Richa
    Osterman, Mark T.
    Paul, Damemarie
    Sokol, Uyen
    Tharmarajah, Soba
    Lawlor, Garrett
    Ahmad, Harris
    Rubin, David T.
    Sands, Bruce E.
    Deepak, Parakkal
    Ungaro, Ryan C.
    GASTROENTEROLOGY, 2024, 166 (05) : S1455 - S1456
  • [45] Long-term safety of 3 years of ozanimod in moderately to severely active ulcerative colitis: an interim analysis of the True North open-label extension
    Panaccione, R.
    Danese, S.
    Wolf, D. C.
    Canavan, J. B.
    Jain, A.
    Wu, H.
    Petersen, A.
    Charles, L.
    Afzali, A.
    Abreu, M. T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 534 - 534
  • [46] Impact of Prior Biologic Exposure on Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North Study
    Bruce, Sands
    Marc, Pondel
    Michael, Silver
    AnnKatrin, Petersen
    Douglas, Wolf
    Remo, Panaccione
    Loftus, Edward, Jr.
    Jean-Frederic, Colombel
    Andreas, Sturm
    Geert, D'Haens
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S8 - S8
  • [47] Efficacy and safety of 3 years of continuous ozanimod treatment: an interim analysis of the True North open-label extension study
    Danese, S.
    Abreu, M. T.
    Wolf, D. C.
    Canavan, J. B.
    Jain, A.
    Wu, H.
    Petersen, A.
    Charles, L.
    Panaccione, R.
    Afzali, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I101 - I102
  • [48] Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study
    David, Hudesman
    Millie, Long
    Douglas, Wolf
    Stephen, Hanauer
    Subrata, Ghosh
    AnnKatrin, Petersen
    Marc, Pondel
    Michael, Silver
    Raymond, Cross
    Brian, Feagan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S9 - S9
  • [49] Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme
    Raine, Tim
    Ishiguro, Yoh
    Rubin, David T.
    Finney-Hayward, Tricia
    Vladea, Ramona
    Liu, John
    Phillips, Charles
    Cheng, Erica
    Targownik, Laura
    Loftus Jr, Edward, V
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (05): : 695 - 707
  • [50] Impact of Ozanimod on C-Reactive Protein Levels and the Association With OZA Efficacy in Patients With Moderately to Severely Active Ulcerative Colitis: Data From the Phase 3 True North Study
    Harris, Sarah
    Maddux, Rachel
    Wu, Chun
    Hu, Yanhua
    Petersen, AnnKatrin
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S868 - S868
12345